GCN2 (EIF2AK4) is a critical regulator of bladder cancer cell viability in response to arginine deprivation therapy Meeting Abstract
| Authors: | Gupta, S.; Mir, M.; Bomalaski, J.; Singh, K.; Harwalkar, J.; Carver, P.; Almasan, A.; Hansel, D. E. |
| Abstract Title: | GCN2 (EIF2AK4) is a critical regulator of bladder cancer cell viability in response to arginine deprivation therapy |
| Meeting Title: | 102nd Annual Meeting of the United States and Canadian Academy of Pathology (USCAP) |
| Journal Title: | Laboratory Investigation |
| Volume: | 93 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2013 Mar 2-8 |
| Meeting Location: | Baltimore, MD |
| ISSN: | 0023-6837 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2013-02-01 |
| Start Page: | 213A |
| End Page: | 214A |
| Language: | English |
| ACCESSION: | WOS:000314789301209 |
| PROVIDER: | wos |
| DOI: | 10.1038/labinvest.2013.21 |
| Notes: | --- - Meeting Abstract: 885 - 102nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) - MAR 02-08, 2013 - Baltimore, MD - "1" - "Source: Wos" |
